GL1X · GenesisL1 explorer

MolNFT v1 · #116021 · protein

Kinase domain of csrc in complex with RL236

5D10 · Proto-oncogene tyrosine-protein kinase src: “Kinase domain of csrc in complex with RL236”. X-ray diffraction, 1 ligand (563), 5 pockets (best druggability 0.62). MolNFT v1 #116021 on GenesisL1: 3D structure, binding sites and…

PDB
5D10
Type
protein
Length
495 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
563
Pockets
5 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein24843% helix, 16% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein24741% helix, 16% strandP00523

Ligands and binding sites

  • 563 · N-[4-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}oxy)phenyl]prop-2-enamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13950.620.7748563
23180.610.7832563
33620.600.7745empty
4750.330.7518empty
5580.280.7415empty

Interfaces

1 interface between chains.

  • A–B · 375 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5D10 · Kinase domain of cSrc in complex with RL236 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.